The effects of a Chinese medicinal suppository (Vitalliver) on insulin‐like growth factor 1 and homocysteine in patients with hepatitis B infection

  title={The effects of a Chinese medicinal suppository (Vitalliver) on insulin‐like growth factor 1 and homocysteine in patients with hepatitis B infection},
  author={Shiu Hon Chui and K. Chan and Albert Ka-Keung Chui and Lili Shek and Ricky N. S. Wong},
  journal={Phytotherapy Research},
The liver is the major organ for the metabolism of homocysteine (Hcy) and production of insulin‐like growth factor 1 (IGF‐1). Hcy metabolism and IGF‐1 synthesis may be impaired in chronic liver diseases. The study investigated the regulatory effect of a Chinese herbal suppository, Vitalliver, on Hcy and IGF‐1, as well as their relationship in patients with hepatitis B infection. Forty patients with chronic hepatitis B virus (HBV) infection without cirrhosis, 25 males and 15 females, were… Expand
Slimpid May Boost Plasma IGF-1 Level and Improve the Quality of Life in Patients with Risk of Developing Metabolic Syndrome
In conclusion, Slimpid may be able to improve QOL of subjects associated with MS, and the delayed increase in IGF-1 might contribute partially to the improvements ofQOL of the test subjects. Expand
Correlations among insulin-like growth factor-1, homocysteine, vitamin B12, and folic acid plasma levels following isotretinoin therapy in acne vulgaris patients
Investigation of the plasma levels of insulin-like growth factor-1, homocysteine, vitamin B12, and folic acid before and after isotretinoin treatment found that younger patients might be at a higher risk of developing vitamin B 12 deficiency and older patients may be at risk of IGF-1 deficiency following isot retinoin therapy. Expand
Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Betaine (BET) is a native compound known for its ability to protect the liver from toxicants. However, few studies have examined the effects of BET on the most common cause of liver disease,Expand
Clinical studies with traditional Chinese medicine in the past decade and future research and development.
Some general issues on the conduct of clinical trials on TCM, such as randomization, control, quality of life (QOL), patient reported outcomes (PROs) and biomarkers, quality control, safety evaluation and case studies, are discussed and accordingly some suggestions are proposed. Expand
The Evolutional Development of Traditional ChineseMedicine (TCM) Outside China Mainland: Challenges,Training, Practice, Research, and Future Development
This overview has provided an account of evolutional changes of an experience-based traditional medical practice of traditional Chinese medicine towards modernisation to keep up with recent advances in analytical and biomedical sciences, and information technology, to help readers to understand why applying biomedical research methodology to TCM modernisation can contribute to gain global appreciation and acceptance of TCM in healthcare. Expand


A panel study on the effects of a Chinese medicinal suppository, Vigconic VI-28, on insulin-like growth factor 1 and homocysteine in healthy men.
It is believed that VI-28 may exert a regulatory effect on the relationship between Hcy and IGF-1, at least in subjects with relatively low levels of Hcy, and an apparent association of hyperhomocysteinemia (Hcy> or =13.0 micromol/l) with decreased IGF- 1. Expand
Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis.
It is concluded that administration of recombinant human growth hormone induces an increase in very low levels of insulin-like growth factor-I, even in patients with cirrhosis with advanced disease, but the clinical benefits remain to be demonstrated. Expand
Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction.
Interestingly, Danshen extract and its pure compounds showed different effectiveness in protecting HUVEC against Hcy-induced injury according to the following descending order: Dansen aqueous extract, 3-(3,4-dihydroxy-phenyl)-2-hydroxy-propionic acid, protocatechuic acid, catechin and protocatechualdehyde. Expand
Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety.
GH therapy can overcome the GH resistance of cirrhosis and the resulting improvement in nitrogen economy and possible influences on clinical outcomes will need to be confirmed in controlled studies of longer duration. Expand
Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease
Substrate availability appears to be a stronger influence on fasting IGF‐1 levels than does insulin, and the close correlation of IGFBP‐3 with liver function indicates a dominant regulatory role of the hepatocyte. Expand
High insulin‐like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance
An important role for IGFBP‐1 in modulating insulin sensitivity in cirrhosis is suggested, as well as a role for GH treatment and somatostatin infusion to suppress GH secretion. Expand
Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation.
Basal hyperhomocysteine concentrations do not change significantly after supplementation with folate and vitamin B-6, but postprandial Hcy metabolism improves, and after vitamin supplementation, the area under the tHcy curve improved in cirrhosis at nearly unchanged basal tH Cy concentrations. Expand
GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study.
RhGH treatment in CLD overcame hepatic GH resistance; 2) may have improved whole-body protein catabolism; 3) increased lipolysis and lipid oxidation; 4) increased insulin resistance; and 5) had potent antinatriuretic effects. Expand
[Detection of serum free insulin-like growth factor 1 in patients with chronic viral hepatitis].
  • M. Lou, N. Song, X. Jin, S. Luo, J. Wang
  • Medicine
  • Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology
  • 2001
Serum free IGF-1 is decreased in patients with liver cirrhosis and severe chronic hepatitis and it can predict the prognosis of patients with severe Chronic hepatitis. Expand
Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis.
Results may indicate that the serum GHBP level reflects the number of hepatic GH receptors, and that the high basal GH level observed in cirrhotic patients is, at least in part, attributable to decreased clearance of GH by these receptors. Expand